TY - JOUR
T1 - Bacterial Resistance to Cephalosporin Treatment in Elderly Stable Patients Hospitalized With a Urinary Tract Infection
AU - Shimoni, Zvi
AU - Salah, Mohamed
AU - Kasem, Amrani
AU - Hermush, Vered
AU - Froom, Paul
N1 - Publisher Copyright:
© 2020 Southern Society for Clinical Investigation
PY - 2020/9
Y1 - 2020/9
N2 - Background: It is unclear if parenteral cephalosporin treatment is appropriate in stable elderly patients hospitalized with a urinary tract infection (UTI) in settings with a high prevalence of bacterial resistant organisms. Methods: We selected 934 consecutive stable patients aged ≥65 years with a UTI, 94.4% (n = 882) treated with a parenteral cephalosporin. Patients were divided into those with and without bacterial resistance to initial antibiotic therapy (BRIAT). Outcome measures were response to antibiotic therapy at 72 hours, prolonged hospitalization (>5 days) and mortality. Results: There were 316 patients (33.8%) with BRIAT. At 72 hours, 33.9% (107/316) did not respond to initial treatment. The odds of a prolonged hospitalization was 2.1 (95% confidence interval–1.6-2.9), but no patient with BRIAT died from urosepsis (0%, 95% confidence interval–0-1.2%). Conclusions: In elderly stable patients hospitalized with a UTI, treatment with a parenteral cephalosporin might be appropriate despite a high prevalence of resistant organisms.
AB - Background: It is unclear if parenteral cephalosporin treatment is appropriate in stable elderly patients hospitalized with a urinary tract infection (UTI) in settings with a high prevalence of bacterial resistant organisms. Methods: We selected 934 consecutive stable patients aged ≥65 years with a UTI, 94.4% (n = 882) treated with a parenteral cephalosporin. Patients were divided into those with and without bacterial resistance to initial antibiotic therapy (BRIAT). Outcome measures were response to antibiotic therapy at 72 hours, prolonged hospitalization (>5 days) and mortality. Results: There were 316 patients (33.8%) with BRIAT. At 72 hours, 33.9% (107/316) did not respond to initial treatment. The odds of a prolonged hospitalization was 2.1 (95% confidence interval–1.6-2.9), but no patient with BRIAT died from urosepsis (0%, 95% confidence interval–0-1.2%). Conclusions: In elderly stable patients hospitalized with a UTI, treatment with a parenteral cephalosporin might be appropriate despite a high prevalence of resistant organisms.
KW - Bacterial resistance
KW - Cephalosporins
KW - Elderly
KW - Hospitalized
KW - Urinary tract infection
UR - http://www.scopus.com/inward/record.url?scp=85085637566&partnerID=8YFLogxK
U2 - 10.1016/j.amjms.2020.05.008
DO - 10.1016/j.amjms.2020.05.008
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32482350
AN - SCOPUS:85085637566
SN - 0002-9629
VL - 360
SP - 243
EP - 247
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 3
ER -